Health economic analysis of allergen immunotherapy for the management of allergic rhinitis, asthma, food allergy and venom allergy: A systematic overview
ConclusionsOverall, the evidence to support the cost‐effectiveness of AIT is limited and of low methodological quality, but suggests that AIT may be cost‐effective for people with allergic rhinitis with or without asthma and in high‐risk subgroups for venom allergy. We were unable to draw any conclusions on the cost‐effectiveness of AIT for food allergy.
Source: Allergy - Category: Allergy & Immunology Authors: M. Asaria, S. Dhami, R. Ree, R. Gerth van Wijk, A. Muraro, G. Roberts, A. Sheikh Tags: REVIEW ARTICLE Source Type: research
More News: Academies | Allergy | Allergy & Immunology | Asthma | Food Allergy | Hay Fever | Immunotherapy | Study